Pioneering access to complex generic products
Drug Discovery World
AUGUST 22, 2023
This will continue to be the case going forward, but the nature of the off-patent landscape will evolve in line with ongoing changes in the segment’s ‘pipeline’: the originator products of today, which will become the generic and biosimilar medicines of tomorrow. There is significant need for more cost-effective generic versions.
52 
Let's personalize your content